Open in app
Sign inGet started

Know Labs Announces Successful Results from Pre-Clinical Study Validating Bio-RFID™ Platform…

SEATTLE, Wash. — June 9, 2021 — Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced…
Go to the profile of Know Labs Inc
Know Labs Inc
Know Labs Confirms Particle Bulb Kills SARS-CoV-2

Know Labs Confirms Particle Bulb Kills SARS-CoV-2

Sign Up for Updates at particlebulb.com
Go to the profile of Know Labs Inc
Know Labs Inc
Know Labs Announces Close of Financing

Know Labs Announces Close of Financing

$14.2 Million for Product Development, Clinical Testing and Preparation for Up List to a Major Exchange
Go to the profile of Know Labs Inc
Know Labs Inc
Know Labs Provides Update on Company Business, Impact of Covid-19

Know Labs Provides Update on Company Business, Impact of Covid-19

Seattle, WA. — December 3, 2020 — OTCQB: KNWN    Know Labs, Inc., an emerging leader in non-invasive medical diagnostics, announced that…
Go to the profile of Know Labs Inc
Know Labs Inc
Know Labs Enters into Research Agreement with Mayo Clinic

Know Labs Enters into Research Agreement with Mayo Clinic

Seattle, WA. — July 21, 2020 — OTCQB: KNWN
Go to the profile of Know Labs Inc
Know Labs Inc
Know Labs Announces Webcast with BioPub

Know Labs Announces Webcast with BioPub

Seattle, WA — April 13, 2020 — OTCQB: KNWN
Go to the profile of Know Labs Inc
Know Labs Inc
Know Labs Granted Patent for its Bio-RFID™ Technology

Know Labs Granted Patent for its Bio-RFID™ Technology

Invention to Disrupt Medical Diagnostics Patent Protected
Go to the profile of Know Labs Inc
Know Labs Inc
Get Our Latest News First
Subscribe
About InsightsLatest StoriesArchiveAbout MediumTermsPrivacyTeams